Editorial: The Golden Future in Medicinal Chemistry: Perspectives and Resources From Old and New Gold-Based Drug Candidates.
作者信息
Massai Lara, Grguric-Sipka Sanja, Liu Wukun, Bertrand Benoît, Pratesi Alessandro
机构信息
Laboratory of Metals in Medicine (MetMed), Department of Chemistry "U. Schiff", University of Florence, Florence, Italy.
Faculty of Chemistry, University of Belgrade, Belgrade, Serbia.
出版信息
Front Chem. 2021 Mar 18;9:665244. doi: 10.3389/fchem.2021.665244. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: The Golden Future in Medicinal Chemistry: Perspectives and Resources From Old and New Gold-Based Drug Candidates.
Front Chem. 2021 Mar 18;9:665244. doi: 10.3389/fchem.2021.665244. eCollection 2021.
2
A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds.
Dalton Trans. 2014 Mar 21;43(11):4209-19. doi: 10.1039/c3dt52524d.
3
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies.
Med Res Rev. 2010 May;30(3):550-80. doi: 10.1002/med.20168.
4
Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives.
Curr Med Chem. 2018 Feb 12;25(4):437-461. doi: 10.2174/0929867324666170529125229.
5
Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action.
J Inorg Biochem. 2008 Mar;102(3):564-75. doi: 10.1016/j.jinorgbio.2007.11.003. Epub 2007 Nov 28.
6
Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes.
ChemMedChem. 2014 Dec;9(12):2781-90. doi: 10.1002/cmdc.201402446. Epub 2014 Nov 5.
7
Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action.
Eur J Med Chem. 2019 Aug 1;175:269-286. doi: 10.1016/j.ejmech.2019.04.062. Epub 2019 May 1.
8
Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes.
Chemistry. 2016 Aug 22;22(35):12487-94. doi: 10.1002/chem.201601542. Epub 2016 Jul 22.
9
Bioinorganic and medicinal chemistry: aspects of gold(I)-protein complexes.
Dalton Trans. 2011 Mar 14;40(10):2099-111. doi: 10.1039/c0dt01057j. Epub 2011 Feb 14.
10
Medicinal Chemistry of Gold Anticancer Metallodrugs.
Met Ions Life Sci. 2018 Feb 5;18. doi: 10.1515/9783110470734-013.
引用本文的文献
1
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt)] pharmacophore is highly cytotoxic against ovarian cancer cells.
Biometals. 2023 Oct;36(5):961-968. doi: 10.1007/s10534-023-00496-8. Epub 2023 Mar 4.
2
Gold (III) Derivatives in Colon Cancer Treatment.
Int J Mol Sci. 2022 Jan 10;23(2):724. doi: 10.3390/ijms23020724.
本文引用的文献
1
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer.
ACS Med Chem Lett. 2019 Feb 7;10(4):656-660. doi: 10.1021/acsmedchemlett.9b00007. eCollection 2019 Apr 11.
2
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: a comparative proteomic study.
Oncotarget. 2018 Jun 15;9(46):28042-28068. doi: 10.18632/oncotarget.25556.
3
Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors.
Free Radic Biol Med. 2018 Nov 1;127:62-79. doi: 10.1016/j.freeradbiomed.2018.03.043. Epub 2018 Mar 27.
4
5
The history of gold therapy in rheumatoid disease.
Semin Arthritis Rheum. 1985 Feb;14(3):180-6. doi: 10.1016/0049-0172(85)90037-x.
Zotero 插件